在多胞膜炎和微观多胞膜炎的粒状瘤中衰老:从病理生理学到临床管理
Baptiste Chevet1,2, Giulia Boscato Sopetto3, Christian Pagnoux4
1LBAI, UMR1227, Univ Brest, Inserm, Brest, France.
Drugs & aging
|May 31, 2025
概括
抗中性粒细胞体抗体 (ANCA) 相关的血管蛋白 (AAV) 影响老年人,对衰老和脆弱有独特的考虑. 管理需要平衡免疫抑制的有效性与副作用,并实施预防措施.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 老年病的医生 老年病的医生
背景情况:
- 反中性粒细胞质抗体 (ANCA) 相关的血管性质 (AAV) 主要影响55-75岁的个体.
- 预期寿命的增加导致75岁以上患者的诊断增加.
- 对于年龄较大的AAV患者,临床试验数据有限,这阻碍了对衰老作用的理解.
研究的目的:
- 探索免疫衰老和衰老对AAV病原和进展的影响.
- 突出特定年龄的AAV表现和管理挑战.
- 对老年AAV患者的现有和新兴治疗策略进行审查.
主要方法:
- 对老年人群中AAV现有文献的审查.
- 对影响AAV呈现和治疗的年龄相关因素的分析.
- 评估临床试验数据和治疗指南.
主要成果:
- 年龄较大的AAV患者可能会出现脏参与度增加和间歇性肺部疾病.
- 脆弱性是老年患者治疗决策的关键因素.
- 利图西马布和潜在的阿瓦科班在老年AAV人群中显示出诱导缓解的希望.
结论:
- 老年人中AAV的管理需要根据免疫和脆弱性进行量身定制的方法.
- 预防感染和减轻葡萄糖皮质醇副作用的预防策略至关重要.
- 需要进一步的研究来优化老年人AAV治疗结果.
相关概念视频
Nephrotic Syndrome III : Nursing Management
51
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
51
Nephrotic Syndrome II : Assessment and Medical Management
26
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
26
Nephrotic Syndrome I : Introduction
37
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
37
Peripheral Artery Disease I: Introduction
37
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
37
Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
Chronic Kidney Disease III: Interprofessional Care
87
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
87


